Cargando…
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
BACKGROUND: This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD). METHODS: Thirty OCD poor responders to previous multiple trials of anti-obsessive medications were selected and admitted to the hospital. Sever...
Autores principales: | Karameh, Wael Karameh, Khani, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772819/ https://www.ncbi.nlm.nih.gov/pubmed/26221004 http://dx.doi.org/10.1093/ijnp/pyv084 |
Ejemplares similares
-
CLOMIPRAMINE IN RESISTANT OBSESSIVE COMPULSIVE DISORDER
por: Khanna, Sumant, et al.
Publicado: (1988) -
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder
por: Seo, Eun Hyun, et al.
Publicado: (2023) -
OBSESSIVE COMPULSIVE NEUROSIS : CLOMIPRAMINE, PROLACTIN AND THERAPEUTIC RESPONSE
por: Ananth, Jambur, et al.
Publicado: (1997) -
In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder
por: Ghumman, Shazia Akram, et al.
Publicado: (2023) -
Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)